Rob Rasing is a highly experienced business professional with a focus on corporate finance and innovation in the tech and healthcare sectors. Currently serving as Managing Partner at Evolute since 2025, Rob specializes in fundraising, mergers and acquisitions, and strategic initiatives for tech pioneers. In addition, Rob holds the role of Investor Relations at AlfaRim Medical, contributing to advancements in cancer treatment. Previously, Rob co-founded RocketX Group, where leadership was directed towards supporting disruptive innovators. Rob's extensive background includes advisory roles at Delft Enterprises B.V., executive leadership as CEO of World & Company, and strategic positions at Olympus Europa and Canon EMEA. Education credentials feature an Executive MBA from IMD, negotiation expertise from Harvard Business School, and a degree in International Business from HAN University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices